Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term follow-up results from the European Randomized Study of Screening for ...

Share on Pinterest A new study found that 1 in 6 males skipped all of their prostate cancer screening appointments, leading to a 45% higher risk of death from the disease. pcess609/Getty Images Men ...

Source: Getty Images Investigators report findings from an analysis of 20-year follow-up data from the ERSPC. Men who consistently avoid prostate cancer screening appointments face a ...